These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 38113560)
1. Synchronous presentation of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: Report of an exceptional case with review of the literature. Khessairi N; Mallek I; Laabidi T; Lahmar A; Bacha D; Slama SB Int J Surg Case Rep; 2024 Jan; 114():109140. PubMed ID: 38113560 [TBL] [Abstract][Full Text] [Related]
2. Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) originating from hepatic progenitor cell: a case report and review of the literature. Hu J; Yuan R; Huang C; Shao J; Zou S; Wang K World J Surg Oncol; 2016 Aug; 14(1):218. PubMed ID: 27535234 [TBL] [Abstract][Full Text] [Related]
3. Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A case report and review of the literature. Qu MM; Zhu YH; Li YX; Li ZF; Li JK; Xu YS; Shrestha M; Lei JQ Medicine (Baltimore); 2021 Nov; 100(46):e27349. PubMed ID: 34797273 [TBL] [Abstract][Full Text] [Related]
4. Combined hepatocellular-cholangiocarcinoma with stem cell features, ductal plate malformation subtype: a case report and proposal of a new subtype. Terada T Int J Clin Exp Pathol; 2013; 6(4):737-48. PubMed ID: 23573322 [TBL] [Abstract][Full Text] [Related]
5. Synchronous development of intrahepatic cholangiocarcinoma and hepatocellular carcinoma in different sites of the liver with chronic B-viral hepatitis: two case reports. Jung KS; Chun KH; Choi GH; Jeon HM; Shin HS; Park YN; Park JY BMC Res Notes; 2013 Dec; 6():520. PubMed ID: 24313990 [TBL] [Abstract][Full Text] [Related]
6. Prognosis of hepatocellular carcinoma expressing cytokeratin 19: comparison with other liver cancers. Lee JI; Lee JW; Kim JM; Kim JK; Chung HJ; Kim YS World J Gastroenterol; 2012 Sep; 18(34):4751-7. PubMed ID: 23002345 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575 [TBL] [Abstract][Full Text] [Related]
8. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis. Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787 [No Abstract] [Full Text] [Related]
9. [Diagnostic value of absent ductular reaction at hepatocellular-stromal boundaries in early stage hepatocellular carcinoma]. Zhang Q; Ma Z; Xin Q; Liu GQ; Liu BB; Gao YT; Zhang CS; Du Z Zhonghua Gan Zang Bing Za Zhi; 2013 Dec; 21(12):924-8. PubMed ID: 24636295 [TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced ultrasound manifestations of synchronous combined hepatocellular-cholangiocarcinoma and hepatocellular carcinoma: A case report. Gao L; Huang JY; Lu ZJ; Lu Q World J Clin Cases; 2022 Apr; 10(11):3615-3623. PubMed ID: 35611203 [TBL] [Abstract][Full Text] [Related]
12. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683 [TBL] [Abstract][Full Text] [Related]
13. Hepatic resection for combined hepatocellular and cholangiocarcinoma. Liu CL; Fan ST; Lo CM; Ng IO; Lam CM; Poon RT; Wong J Arch Surg; 2003 Jan; 138(1):86-90. PubMed ID: 12511158 [TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material. Al-Muhannadi N; Ansari N; Brahmi U; Satir AA Ann Hepatol; 2011; 10(4):508-15. PubMed ID: 21911893 [TBL] [Abstract][Full Text] [Related]
16. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population. Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma. Wu H; Liu Y; Jiang XW; Li WF; Guo G; Gong JP; Ding X Tumour Biol; 2016 Oct; 37(10):13499-13508. PubMed ID: 27465555 [TBL] [Abstract][Full Text] [Related]
18. Synchronous double cancers of primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a case report and review of the literature. Wu C; Bai DS; Jiang GQ; Jin SJ World J Surg Oncol; 2014 Nov; 12():337. PubMed ID: 25385169 [TBL] [Abstract][Full Text] [Related]
19. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Sapisochin G; Fidelman N; Roberts JP; Yao FY Liver Transpl; 2011 Aug; 17(8):934-42. PubMed ID: 21438129 [TBL] [Abstract][Full Text] [Related]
20. Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma: outcome after liver transplantation. Maganty K; Levi D; Moon J; Bejarano PA; Arosemena L; Tzakis A; Martin P Dig Dis Sci; 2010 Dec; 55(12):3597-601. PubMed ID: 20848202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]